Medicaid Archive

Clear Filters

… results in Medicaid.

April 14, 2022
NHeLP comments on Oregon’s application for renewal of the Oregon Health Plan § 1115(a) Demonstration Waiver for 2022-2027
Sarah Somers and Wayne Turner Comments
In public comments, NHeLP expresses support for Oregon's decision to abandon its waiver of EPSDT. However, NHeLP strongly opposes Oregon's proposal to exclude outpatient prescription drugs approved under the FDA's accelerated approval pathway. Denying Medicaid enrollees access to effective break-through therapies would harm people with serious or life-threatening medical…
Read more
April 12, 2022
NHeLP Comments on the Proposed Update to the CDC’s Opioid Prescribing Guidelines
Héctor Hernández-Delgado and Alexis Robles-Fradet Comments
In these comments to the Centers for Disease Control and Prevention (CDC), NHeLPs conveys its support for the CDC's proposal to update the 2016 Opioid Prescribing Guidelines. NHeLP's comments highlight the negative consequences the 2016 guidelines have had on access to medically necessary opioid medications for pain, particularly for…
Read more
April 8, 2022
More Transparency Needed to Ensure Medicaid Beneficiaries Have Access to Necessary Off-Label Prescription Drugs
Abigail Coursolle Issue Brief
Under federal law, state Medicaid programs are required to cover (with a few exceptions) outpatient prescription drugs for “medically accepted indications.” Medically accepted indications are both those that are included on the drug’s label by the FDA as part of the approval process, and certain “off-label” uses.Medicaid programs are…
Read more
April 6, 2022
Q&A: Recent EPSDT Cases
Jane Perkins and Amanda Avery Court Document, Health Advocate, NHeLP Matters, Q&A
Read more
February 25, 2022
Fact Sheet: Private Enforcement of the Medicaid Act Under 42 U.S.C. § 1983
Jane Perkins Fact Sheet
Read more
February 9, 2022
Eliminating Barriers to Medication-Assisted Treatment in Medicaid
Cathren Cohen Issue Brief
Few individuals with opioid use disorder currently have access to medication-assisted treatment, a highly effective overdose prevention treatment. As the single largest payer of OUD treatment, Medicaid has an important role to play in reducing barriers and increasing access. In this issue brief, we identify persiting barriers to MAT coverage…
Read more

Medicaid Archive

Never miss a thing.

Subscribe today.

NHeLP comments on Oregon’s application for renewal of the Oregon Health Plan § 1115(a) Demonstration Waiver for 2022-2027

NHeLP Comments on the Proposed Update to the CDC’s Opioid Prescribing Guidelines

More Transparency Needed to Ensure Medicaid Beneficiaries Have Access to Necessary Off-Label Prescription Drugs

Q&A: Recent EPSDT Cases

Fact Sheet: Private Enforcement of the Medicaid Act Under 42 U.S.C. § 1983

Eliminating Barriers to Medication-Assisted Treatment in Medicaid